Related Experiment Video
Updated: Jun 27, 2025

Author Spotlight: Exploring the Role of Ion Channels in Cancer: Characterization and Potential Treatment Approaches
Published on: June 16, 2023
Phenazine Cations as Anticancer Theranostics†
Felicity F Noakes1,2, Kirsty L Smitten1,3, Laura E C Maple2
1Department of Chemistry, The University of Sheffield, Western Bank, Sheffield S3 7HF, U.K.
Abstract:
The biological properties of two water-soluble organic cations based on polypyridyl structures commonly used as ligands for photoactive transition metal complexes designed to interact with biomolecules are investigated. A cytotoxicity screen employing a small panel of cell lines reveals that both cations show cytotoxicity toward cancer cells but show reduced cytotoxicity to noncancerous HEK293 cells with the more extended system being notably more active. Although it is not a singlet oxygen sensitizer, the more active cation also displayed enhanced potency on irradiation with visible light, making it active at nanomolar concentrations. Using the intrinsic luminescence of the cations, their cellular uptake was investigated in more detail, revealing that the active compound is more readily internalized than its less lipophilic analogue. Colocalization studies with established cell probes reveal that the active cation predominantly localizes within lysosomes and that irradiation leads to the disruption of mitochondrial structure and function. Stimulated emission depletion (STED) nanoscopy and transmission electron microscopy (TEM) imaging reveal that treatment results in distinct lysosomal swelling and extensive cellular vacuolization. Further imaging-based studies confirm that treatment with the active cation induces lysosomal membrane permeabilization, which triggers lysosome-dependent cell-death due to both necrosis and caspase-dependent apoptosis. A preliminary toxicity screen in the Galleria melonella animal model was carried out on both cations and revealed no detectable toxicity up to concentrations of 80 mg/kg. Taken together, these studies indicate that this class of synthetically easy-to-access photoactive compounds offers potential as novel therapeutic leads.
Insights
Two novel polypyridyl organic cations show selective cancer cell toxicity and enhanced photoactivity. The more active cation induces lysosome-dependent cell death at nanomolar concentrations with minimal animal toxicity.
Area of Science:
- Medicinal Chemistry
- Photochemistry
- Cell Biology
Background:
- Polypyridyl compounds are versatile ligands for photoactive metal complexes.
- Investigating their biological properties is crucial for therapeutic applications.
- Understanding structure-activity relationships guides the design of novel agents.
Purpose of the Study:
- To investigate the biological properties and therapeutic potential of two water-soluble polypyridyl organic cations.
- To evaluate their cytotoxicity, cellular uptake, and mechanism of action.
- To assess their preliminary toxicity in an animal model.
Main Methods:
- Cytotoxicity screening across various cell lines.
- Cellular uptake studies using intrinsic luminescence.
- Confocal microscopy and stimulated emission depletion (STED) nanoscopy.
- Transmission electron microscopy (TEM) for ultrastructural analysis.
- Galleria melonella toxicity assay.
Main Results:
- Both cations exhibited selective cytotoxicity against cancer cells versus HEK293 cells.
- The more extended cation showed enhanced photoactivity, inducing cell death at nanomolar concentrations upon visible light irradiation.
- Cellular uptake studies revealed preferential internalization of the more lipophilic cation.
- Treatment led to lysosomal swelling, mitochondrial dysfunction, and lysosome-dependent cell death (necrosis and apoptosis).
- No detectable toxicity was observed in the Galleria melonella model up to 80 mg/kg.
Conclusions:
- Polypyridyl organic cations represent a promising class of photoactive compounds for therapeutic development.
- The active cation demonstrates potent, light-activated cytotoxicity with a favorable preliminary safety profile.
- Further investigation is warranted to explore their therapeutic efficacy and optimize their design.
More Related Videos
07:20Amide Coupling Reaction for the Synthesis of Bispyridine-based Ligands and Their Complexation to Platinum as Dinuclear Anticancer Agents
Published on: May 28, 2014
15:04Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation
Published on: January 19, 2019
Related Concept Videos
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
Phenothiazines, such as prochlorperazine...
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
Targeted Cancer Therapies
There are several types of targeted therapies against...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...